Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. (KLDO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KLDO · as of Jun 8, 2026
Key Statistics
Explore Kaleido Biosciences, Inc. Data
kldo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
kldo competitorsKLDO
ARNI
BTTX
BXRXQ
CALA
IVBTStock Performance
Full HistoryAbout Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disord…
what is kaleido biosciences, inc. · kldo stock overview · kaleido biosciences, inc. company profile · who is kaleido biosciences, inc. ceo · kldo OTC · kaleido biosciences, inc. headquarters · kaleido biosciences, inc. business segments
About Stock Overview & Key Data
Kaleido Biosciences, Inc. (KLDO) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 28, 2019. As of the latest trading session, KLDO stock price is $0.00, with a market capitalization of $4,262. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Kaleido Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2021, Kaleido Biosciences, Inc. reported revenue of $1.1M and net income of -$90.3M. For detailed data — including Kaleido Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kaleido Biosciences, Inc. (KLDO) stock price is $0.00. The stock is traded on OTC under the ticker symbol KLDO. The 52-week range is $0.00 – $0.19.